Anticentromere Antibody as a Risk Factor for Cancer in Patients with Systemic Sclerosis

Risk of Cancer in Patients with Dermatomyositis or Polymyositis

Bárður Sigurgeirsson, Bernt Lindelöf, Olof Edhag et al. · New England Journal of Medicine · 1992 · 795 citations · Full text

Medicine, Dermatology, Oncology +17

Effects of cyclophosphamide on the development of malignancy and on long‐term survival of patients with rheumatoid arthritis a 20‐year followup study

Charles D. Radis, Leslie E. Kahl, Gary L. Baker et al. · Arthritis & Rheumatism · 1995 · 315 citations

Medicine, Internal Medicine, Oncology +13

Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy.

Intisar Husain, James L. Mohler, H F Seigler et al. · PubMed · 1994 · 245 citations

Medicine, Oncology, Pharmacology +13

Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis

Virginia Steen, Gayle L. Ziegler, Gerald P. Rodnan et al. · Arthritis & Rheumatism · 1984 · 225 citations

Medicine, Immunology, Pathology +9

Clinical associations of anticentromere antibodies and antibodies to topoisomerase i. a study of 355 patients

Ethan S. Weiner, William C. Earnshaw, J.‐L. SeneAcal et al. · Arthritis & Rheumatism · 1988 · 221 citations

Life Sciences, Immunology, Internal Medicine +10